Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Thermo Fisher Scientific Expands Middleton, Wisconsin, GMP-Bioanalytical Complex

06/19/2024
Thermo Fisher Scientific Inc., a global supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services, plans to expand its operations in Middleton, Wisconsin. The $58 million project is expected to create 350 jobs.

The investment includes a new 72,500-square-foot facility, located at the company’s good manufacturing practices (GMP) lab, which will be dedicated to PPD, its clinical research brand.

“As research in biopharmaceutical therapies continues to rapidly expand, we are excited to expand our overall capacity and capabilities in laboratory services to help our customers deliver therapies that meet the highest quality and safety standards for patients,” said Leon Wyszkowski, president of analytical services, clinical research, at Thermo Fisher Scientific. “We will continue to support and empower our customers as they continue to discover, develop, and deliver new groundbreaking therapies. This $58 million investment to expand the site is a testament to our dedication in supporting Thermo Fisher’s Mission of making the world healthier, cleaner, and safer.”

The Wisconsin Economic Development Corporation (WEDC) is supporting the project by authorizing up to $2.15 million in performance-based business development tax credits through September 2026. The actual amount of tax credits Thermo Fisher Scientific will receive is contingent upon the number of jobs created and the amount of capital investment during that period.

“Thermo Fisher plays a key role in our state’s biohealth and biotechnology industry by providing many of the clinical services companies need to bring safe and effective treatments to patients,” noted WEDC Secretary and CEO Missy Hughes. “Their continued growth is a huge win for innovation in our state.”

In addition to Thermo Fisher Scientific’s GMP and bioanalytical labs in Middleton, the PPD clinical research business includes bioanalytical, biomarker, and vaccine sciences labs in Richmond, Virginia; a GMP lab in Athlone, Ireland; central labs and biomarker operations in Brussels, Belgium, Highland Heights, Kentucky, and Singapore; and bioanalytical, biomarker, vaccine sciences, and central labs in Suzhou, China.

Exclusive Research